The U.S. Centers for Disease Control and Prevention (CDC) today reported that from February 2022–May 2023, hospitalizations for Respiratory Syncytial Virus (RSV) were less frequent but were associated with more severe disease than hospitalizations for influenza or SARS-CoV-2 virus infections.
And there were substantial variations in hospital admissions observed for RSV and influenza, but SARS-CoV-2 coronavirus infection admissions exhibited less seasonal variation.
RSV Vaccination May Protect Seniors from Hospitalization
Pediatric Mental Health Care Use, Spending Both Up >20 Percent Since the Pandemic
Study shows telehealth delivery of mental health care persists
Most Seniors With RSV-Linked Hospitalization Are Aged ≥75
And patients aged ≥60 years hospitalized with RSV are more likely to have severe illness than those with COVID-19, influenza
Severe SARS-CoV-2 Appears to Infect Coronary Vessels
SARS-CoV-2 targets plaque macrophages, and its entry is increased in cholesterol-loaded primary macrophages
CDC Stops Issuing New COVID-19 Vaccination Cards
The cards people have at home can still be used as proof of vaccination
In Early Trial, Results Promising for Moderna Combo COVID-Flu Vaccine
Moderna hopes to get federal regulatory approval for the combined vaccine in 2025
FDA Approves Updated Novavax COVID-19 Vaccine
Updated shot is expected to better target variants that are circulating now and help prevent hospitalization and death from the virus
COVID-19 Infection, Vaccination Have Little Effect on Migraine Worsening
Increased concern about migraine worsening was risk factor for perceived migraine worsening
In-Hospital Mortality Evaluated for SARS-CoV-2-Linked Sepsis
March 2020 to November 2022 saw decline in crude in-hospital mortality for SARS-CoV-2-linked sepsis from 33.4 to 14.9 percent
Nirmatrelvir/Ritonavir Cuts COVID-19 Complications in Highest-Risk Patients
Risk for COVID-19 hospitalization or death reduced for those who were severely or moderately immunocompromised